SCHEMBL3759716

SCHEMBL3759716

CN(C)c1ccc(N2C(=O)C=CC2=O)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 14/20 0.65
FAAH O00519 5/20 0.65
MAPK1 P28482 2/20 0.54
HSP90AA1 P07900 1/20 0.54
PKM P14618 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
ALDH1A1 P00352 2/20 0.51
KDM4E B2RXH2 1/20 0.51
MEN1 O00255 1/20 0.51
GAA P10253 1/20 0.51
MAPT P10636 1/20 0.51
RECQL P46063 1/20 0.51
KMT2A Q03164 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
DDAH1 O94760 1/20 0.48
BCHE P06276 1/20 0.48
ALOX15 P16050 1/20 0.48
TSHR P16473 1/20 0.48
HSD17B10 Q99714 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4289960 0.89 MGLL (0.52) MGLLFAAHMAPK1HSP90AA1PKM
SCHEMBL458382 0.89 MGLL (0.52) MGLLFAAHMAPK1HSP90AA1PKM
SCHEMBL8467655 0.89 HSP90AA1 (0.64) MGLLFAAHMAPK1HSP90AA1PKM
SCHEMBL5150580 0.89 MGLL (0.52) MGLLFAAHMAPK1PKMNPSR1
SCHEMBL3665727 0.87 MGLL (0.65) MGLLFAAHMAPK1HSP90AA1PKM
SCHEMBL27650867 0.85 MGLL (0.50) MGLLFAAHMAPK1HSP90AA1PKM
SCHEMBL3672504 0.82 MGLL (0.71) MGLLFAAHMAPK1HSP90AA1PKM
SCHEMBL95324 0.81 MGLL (1.00) MGLLFAAHMAPK1HSP90AA1PKM
SCHEMBL7062361 0.80 MGLL (0.61) MGLLFAAHMAPK1HSP90AA1PKM
SCHEMBL28774595 0.78 MEN1 (0.62) MGLLFAAHMAPK1HSP90AA1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5821300-A MONOMERS INCLUDE ORGANOTIN-CONTAINING (METH)ACRYLATES AND N-SUBSTITUTED MALEIMIDES WITCO GMBH (DE) 1998-10-13 US claimed
EP-0841353-A1 Process for the preparation of polymeric binders and their application as antifouling paint Witco GmbH (DE) 1998-05-13 EP claimed
CN-114574223-A Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal element JSR株式会社 2022-06-03 CN disclosed
CN-107045064-A A kind of pre-treating method of polypeptide based on derivatization in plasma sample 中国药科大学 2017-08-15 CN disclosed
WO-2012117367-A1 PROBE AND PRIMER SEQUENCES FOR DETECTION OF HEPATITIS B VIRUS BY REAL-TIME PCR, PCR REACTION MIXTURE AND KITS THEREOF. BIGTEC PRIVATE LIMITED (IN) 2012-09-07 WO disclosed
WO-2012095714-A1 PROBES AND PRIMERS FOR DETECTING TYPHOID BIGTEC PRIVATE LIMITED (IN) 2012-07-19 WO disclosed
US-20100305121-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE BURHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2010-12-02 US disclosed
US-20100305121-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE BURHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2010-12-02 US disclosed
US-20100305121-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE BURHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2010-12-02 US disclosed
US-20070203236-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE UNITED STATES GOVERNMENT 2007-08-30 US disclosed
US-20070203236-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE UNITED STATES GOVERNMENT 2007-08-30 US disclosed
US-20070203236-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE UNITED STATES GOVERNMENT 2007-08-30 US disclosed
EP-1190244-B1 METHOD OF PRODUCING MONOLITHIC SUPPORT MATERIALS BUCHMEISER MICHAEL RUDOLF (AT) 2003-02-26 EP disclosed
EP-1190244-A1 METHOD OF PRODUCING MONOLITHIC SUPPORT MATERIALS MERCK PATENT GmbH (DE) 2002-03-27 EP disclosed
WO-2000073782-A1 METHOD OF PRODUCING MONOLITHIC SUPPORT MATERIALS MERCK PATENT GMBH (DE) 2000-12-07 WO disclosed
US-5821300-A MONOMERS INCLUDE ORGANOTIN-CONTAINING (METH)ACRYLATES AND N-SUBSTITUTED MALEIMIDES WITCO GMBH (DE) 1998-10-13 US disclosed
EP-0841353-A1 Process for the preparation of polymeric binders and their application as antifouling paint Witco GmbH (DE) 1998-05-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203236-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE FADS2, ACOT7, FADS1 MGLL 316/4885FAAH 85/4885MAPK1 3195/4885
US-20100305121-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE FADS2, ACOT7, FADS1 MGLL 316/4885FAAH 85/4885MAPK1 3195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.